ALFA Filings
Every announcement, straight from the exchange
Every TruAlt Bioenergy earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements with these filters
TruAlt reported massive 606% YoY revenue growth, turning profitable despite raw material price surges. Management is pivoting from ethanol to high-margin CBG to insulate from feedstock volatility.
Q2 FY27 consolidated total income ₹823.74 Cr, PAT ₹34.99 Cr, EBITDA margin 12.47%. H1 PAT ₹94.27 Cr, EBITDA ₹233.92 Cr (16.27% margin). Strategy: integrated bioenergy across ethanol, CBG, SAF, retail.
TruAlt Bioenergy reported massive YoY growth in Q1 FY27, driven by a strategic pivot to multi-feed ethanol operations and inventory of lower-cost maize.
TruAlt Bioenergy reported strong Q1FY27 consolidated performance with Total Income of ₹641.41 Cr, up 96.4% YoY. Strategy centers on dual-feed ethanol integration and expansion into CBG and SAF verticals.
TruAlt Bioenergy reported FY26 standalone revenue of ₹1,704cr (down from ₹1,880cr) due to low OMC tender allocations. EBITDA margin improved to 19.81%. Transitioning to a diversified biofuels platform.
TruAlt Bioenergy reported FY26 consolidated revenue of ₹1813.96 Cr and PAT of ₹96.87 Cr. The company is transitioning to a multi-feed, year-round ethanol platform.